(Q34066000)

30 July 2017

title

Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia. (English)

1 reference

30 July 2017

0 references

1 reference

Knauf WU

1

1 reference

30 July 2017

Langenmayer I

2

1 reference

30 July 2017

Ehlers B

3

1 reference

30 July 2017

Mohr B

4

1 reference

30 July 2017

Adorf D

5

1 reference

30 July 2017

Nerl CH

6

1 reference

30 July 2017

Hallek M

7

1 reference

30 July 2017

Zwingers TH

8

1 reference

30 July 2017

Emmerich B

9

1 reference

30 July 2017

Thiel E

10

1 reference

30 July 2017

publication date

1 November 1997

1 reference

30 July 2017

1 reference

30 July 2017

volume

27

1 reference

30 July 2017

issue

5-6

1 reference

30 July 2017

page(s)

523-532

1 reference

Chronic lymphocytic leukemia: new insights into biology and therapy

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Expression of Tac antigen on activated normal human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058320

10.3109/10428199709058320

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference